Navigation Links
Cambrex Reports First Quarter 2009 Results
Date:5/5/2009

itable raw materials or packaging materials, the Company's ability to receive regulatory approvals for its products and other factors described under the caption "Risk Factors That May Affect Future Results" in the Company's annual report on Form 10-K for the year ended December 31, 2008. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time and it is not possible for the Company to predict which will arise. In addition, the Company cannot assess the impact of each factor on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

For further details and a discussion of these and other risks and uncertainties, investors are cautioned to review the Cambrex 2008 Annual Report on Form 10-K, including the Forward-Looking Statement section therein, and other filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including APIs, advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. The Company currently employs approximately 850 people worldwide. For more information, please visit www.cambrex.com



                               CAMBREX CORPORATION
                          Statement of Profit and Loss
                 For the Quarters Ended March 31, 2009 and 
'/>"/>
SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cambrex Receives Notice Regarding NYSE Listing
2. Cambrex Reports Third Quarter 2008 Results
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
5. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
6. Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
7. TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
8. United Therapeutics Reports First Quarter 2009 Financial Results
9. Osteotech Reports First Quarter 2009 Financial Results
10. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
11. Idenix Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Deep Knowledge Ventures last week sponsored ... Longevity Research’ and welcomed a host of London-based ... Innovation Center for the event, organised by the ... The meeting highlighted the need for both philanthropic ... disease, as well as the crucial role of ...
(Date:7/10/2014)... OMICS Group’s 5th International conference and exhibition ... at Double Tree by Hilton Beijing, China is all ... & Bioanalytical research methods only to facilitate improved living ... Dr. Srinubabu Gedela, MD of OMICS Group Inc has ... one in bringing a unique and international mix of ...
(Date:7/10/2014)... -- Kainos Capital, a firm specializing in acquiring and managing ... acquired the Slim-Fast brand from Unilever. Unilever will retain ... transaction were not disclosed. Slim-Fast is a ... ready-to-drink shakes, powders, bars and snacks to retail customers ... the United Kingdom and Ireland.  ...
(Date:7/10/2014)... of Adelaide research may help in the fight against ... detect tiny quantities of explosives with the use of ... journal Sensors and Actuators B: Chemical , the ... detect explosives in concentrations as low as 6.3 ppm ... only a few minutes. , "Traditionally explosives detection has ...
Breaking Biology Technology:DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2
... Roy came into CUNA Mutual Groups IT shop, he wasnt ... Steve Haroldson, retired leaving its IT organization with strong connections ... As the new guy with big shoes to fill, Rick ... ,Rick and CUNA both recognized that when you tie IT ...
... new job-finding site IT chief becomes marketer ... WARF to put on patent-strategy conference ... UW grads get new job-finding site ,The Wisconsin Alumni ... graduates find jobs, called Badger Access . The site uses ...
... Wis. What does it mean to the biotech ... That question should be thoroughly addressed at the Wisconsin ... Labs: Where Science Spawns Novel Therapies. The conference will be ... be a biotechnology showcase about 20 companies, 11 from ...
Cached Biology Technology:CIO of CUNA Mutual Group talks on business-IT fusion 2CIO of CUNA Mutual Group talks on business-IT fusion 3Tech Digest: whats moving in the Midwest (11/3/04) 2Life-sciences conference to feature novel research with clinical potential 2
(Date:7/10/2014)... , June 30, 2014  Aware, Inc. (NASDAQ: ... and services, previously announced on June 26, 2014 that ... dividend of $1.75 per share, or approximately $40 million ... July 10, 2014 and a payment date of July ... that it had set an ex-dividend date for this ...
(Date:7/10/2014)... 2, 2014 It is a great honor ... appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark ... Dr. Ginsburg, with over 34 years of experience, ... and Good Samaritan Regional Medical Center. Dr. Ginsburg has ... 1980,s and is considered an expert in the implantation ...
(Date:7/10/2014)... , July 3, 2014 Research ... addition of the "Global Gesture Recognition & ... - Forecasts to 2020" report to their ... Global Gesture Recognition & Touch-Less Sensing Market ... around for a while, but the companies were ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... who has watched crime dramas on TV knows that ... from evidence gathered at a crime scene, establish a ... has been wrongly jailed. A lesser known but rapidly ... paternal ancestrya process known as genetic genealogy. The laboratories ...
... symptoms until it has spread to other organs, when it ... great promise for extending survival during later disease stages, but ... of the first discoveries of its kind, UC Davis Cancer ... own repair mechanism and, in so doing, help make chemotherapy ...
... Texas Health Science Center at Houston (UTHSC-Houston) were honored ... at the 2008 American Heart Association,s Scientific Sessions in ... killer. UT faculty members recognized were: Nobel Laureate ... Foundation Institute of Molecular Medicine for the Prevention of ...
Cached Biology News:NIST guides genetic genealogy labs toward improved accuracy 2UC Davis discovery offers hope for treating kidney cancer 2UT faculty members win American Heart Association awards for advancing research 2UT faculty members win American Heart Association awards for advancing research 3
... Rabbits x 2 , ... bleed x1 /each , Immunizations/Boost injections ... (app. 5 ml) x1 /each , ... /each , Final Bleed ~ 100 ml blood ...
Mouse VCAM-1/CD106 MAb (Clone 112702)...
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*...
Request Info...
Biology Products: